Sleep Software Market To Hit USD 1,569.2 Million By 2030 With 10.1% CAGR Marketsandmarketstm
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, ...